Company intelligence / Profile preview

IntraOp Medical

Sunnyvale, California, United States

Ownership: Private
Employees: ~85
Development stage: Other

Overview

IntraOp has completed the world's first Phase II Electron FLASH Trial comparing FLASH radiotherapy to conventional radiotherapy for non-melanoma skin cancer. The company has installed its 10th Mobetron with FLASH-IQ system worldwide and successfully treated the first pancreatic cancer patient using intra-operative radiation therapy with electrons at Vanderbilt University Medical Center.

Therapeutic areas: Oncology
Modalities: DeviceRadiopharmaceutical
Industry: Therapeutic Medical Devices

Partnerships

University Hospital of Lausanne (CHUV)Vanderbilt University Medical CenterHeidelberg University Hospital

Beyond the preview

Go deeper on IntraOp Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IntraOp Medical.

Explore the full profile